Analyst stock forecast
RenovoRx Forecast: $7.13 Analyst Target
Direct answer
RenovoRx's average price target is $7.13.
The target implies +525% from the recorded current price, and the consensus rating is none.
The low target implies +163.2%, the high target implies +1,171.9%, and the range spans 1,008.8% of the current price.
Forecast evidence checked October 19, 2026.
Get free RenovoRx email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.14
- Average price target
- $7.13
- High price target
- $14.50
- Low price target
- $3.00
- Low target gap
- +163.2%
- Target upside
- +525%
- High target gap
- +1,171.9%
- Target range width
- 1,008.8%
- Consensus rating
- none
- Analysts
- 4
- Evidence date
- October 19, 2026
- Valid through
- October 26, 2026
Explore related company data
Read the frequently asked questions.
What is RenovoRx's average price target?
RenovoRx's verified average price target is $7.13. The target range is $3.00 to $14.50.
How far are RenovoRx's low and high targets from the recorded price?
The low target implies +163.2%, while the high target implies +1,171.9%.
How many analysts are included in RenovoRx's consensus?
The verified consensus includes 4 analysts.
How is RenovoRx's target upside or downside calculated?
The average target of $7.13 is divided by the recorded price of $1.14, then one is subtracted to produce +525%. This does not guarantee a future return.
When was RenovoRx's analyst forecast verified?
The data was verified on 2026-10-19. The dataset is valid through 2026-10-26.